AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 SEP 4 - (NewsRx.com & NewsRx.net) -- Leptin and hCG modulate new vessel growth at the maternal/fetal interface.
According to published research from Switzerland, "vascular endothelial growth factor (VEGF) has been identified as an endothelium-specific mitogen and inducer of angiogenesis and endothelial cell survival. Leptin and hCG have also been suggested as possible regulators of angiogenesis in various models. In-vivo and in-vitro assays revealed that leptin has an angiogenic activity and that the vascular endothelium is a target for leptin."
"Thus, we hypothesized that products of cytotrophoblastic cells may play a role in placental angiogenesis and we therefore investigated the effects of leptin and hCG on cytotrophoblast VEGF secretion. We incubated cytotrophoblastic cells (CTB) with recombinant human leptin (rhLept) (0-4 pg/ml) or hCG (0-30 000 IU/ml) for 4 hours," said D. Islami and colleagues, University of Geneva, Cantonal Hospital.
"RhLept significantly stimulated hCG (P=0.0045) and decreased VEGF release (P=0.0008) by CTB in a concentration-dependent manner. On the other hand, increasing concentrations of hCG (0-30,000 IU/ml), induced a significant inhibition of leptin secretion (P=0.0028) and a marked dose-dependent stimulation of VEGF(165) secretion (P
...
Source: HighBeam Research, Leptin and hCG modulate new vessel growth at the maternal/fetal...